S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Stocks are for suckers – try this instead (Ad)
UK travelers face hours-long waits for ferries to France
'War of the states': EV, chip makers lavished with subsidies
Stocks are for suckers – try this instead (Ad)
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
Stocks are for suckers – try this instead (Ad)
Shipbuilder Austal executives accused of inflating earnings
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Stocks are for suckers – try this instead (Ad)
UK travelers face hours-long waits for ferries to France
'War of the states': EV, chip makers lavished with subsidies
Stocks are for suckers – try this instead (Ad)
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
Stocks are for suckers – try this instead (Ad)
Shipbuilder Austal executives accused of inflating earnings
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Stocks are for suckers – try this instead (Ad)
UK travelers face hours-long waits for ferries to France
'War of the states': EV, chip makers lavished with subsidies
Stocks are for suckers – try this instead (Ad)
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
Stocks are for suckers – try this instead (Ad)
Shipbuilder Austal executives accused of inflating earnings
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Stocks are for suckers – try this instead (Ad)
UK travelers face hours-long waits for ferries to France
'War of the states': EV, chip makers lavished with subsidies
Stocks are for suckers – try this instead (Ad)
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
Stocks are for suckers – try this instead (Ad)
Shipbuilder Austal executives accused of inflating earnings
No more room for vroom? Paris votes on banishing e-scooters
ETR:BAYN

Bayer Aktiengesellschaft - BAYN Stock Forecast, Price & News

€58.72
+0.94 (+1.63%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
€58.00
€59.00
50-Day Range
€55.48
€62.49
52-Week Range
€46.70
€67.99
Volume
2.44 million shs
Average Volume
N/A
Market Capitalization
$57.69 billion
P/E Ratio
14.01
Dividend Yield
4.09%
Price Target
N/A

BAYN stock logo

About Bayer Aktiengesellschaft (ETR:BAYN) Stock

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Receive BAYN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

BAYN Stock News Headlines

Did You See These Trend Reversals?
Get ready for a potentially shocking and unprecedented announcement from the Fed meeting on May 3rd. This could cause many retail and industry traders to resort to drastic measures. One swift stroke could make popular assets plummet, BUT… there’s a straightforward solution to act now to protect your family and wealth. pixel
Bayer sees lower 2023 operating profit on cost inflation
Bayer AG: Potential To Double Over 12-18 Months
What To Do With Your Trades Today
There’s a tool that scans and picks the best stocks… and could give you all the consistency you need in your trading… No matter what happens in the market. Revealed Here: A.I. Predicted Stock Forecasts pixel
Bayer under investor pressure to speed up CEO changeover
Activist Investor Builds Stake In Bayer, Pushes Breakup
Bayer, Oregon finalize $698 million PCB pollution settlement
See More Headlines
Receive BAYN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Drug Manufacturers - Major
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
95,950
Year Founded
N/A

Profitability

Net Income
$4.15 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$50.74 billion
Cash Flow
€10.26 per share
Book Value
€39.47 per share

Miscellaneous

Free Float
N/A
Market Cap
$57.69 billion
Optionable
Not Optionable
Beta
1.16

Key Executives

  • Mr. Werner Baumann (Age 61)
    Chairman of Management Board, CEO & Chief Sustainability Officer
    Comp: $5.7M
  • Mr. Wolfgang U. Nickl (Age 54)
    CFO & Member of Management Board
    Comp: $2.25M
  • Mr. Heiko W. J. Schipper (Age 54)
    Member of Management Board & Pres of the Consumer Health Division
    Comp: $2.43M
  • Mr. Stefan Oelrich (Age 55)
    Head of the Pharmaceuticals Division & Member of the Board of Management
    Comp: $3.01M
  • Ms. Sarena S. Lin (Age 52)
    Chief Transformation & Talent Officer, Labor Director and Member of Management Board
    Comp: $3.17M
  • Mr. Rodrigo Santos (Age 50)
    Member of Management Board & Pres of the Crop Science Division
  • Mr. Bernd-Peter Bier (Age 56)
    Head of Accounting and Head of Taxes
  • Mr. Oliver Maier
    Head of Investor Relations
  • Dr. Gabriel Harnier (Age 52)
    Head of Law, Patents & Compliance
  • Mr. Michael Preuss
    Head of Communications, Gov. Relations and Corp. Brand













BAYN Stock - Frequently Asked Questions

How have BAYN shares performed in 2023?

Bayer Aktiengesellschaft's stock was trading at €48.33 at the start of the year. Since then, BAYN shares have increased by 21.5% and is now trading at €58.72.
View the best growth stocks for 2023 here
.

Is Bayer Aktiengesellschaft a good dividend stock?

Bayer Aktiengesellschaft (ETR:BAYN) pays an annual dividend of €2.40 per share and currently has a dividend yield of 4.29%. BAYN has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 57.28%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of Bayer Aktiengesellschaft own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bayer Aktiengesellschaft investors own include NVIDIA (NVDA), Intel (INTC), Cisco Systems (CSCO), Walt Disney (DIS), Lam Research (LRCX), QUALCOMM (QCOM), SAP (SAP), AbbVie (ABBV), Applied Materials (AMAT) and Advanced Micro Devices (AMD).

What is Bayer Aktiengesellschaft's stock symbol?

Bayer Aktiengesellschaft trades on the ETR under the ticker symbol "BAYN."

What is Bayer Aktiengesellschaft's stock price today?

One share of BAYN stock can currently be purchased for approximately €58.72.

How much money does Bayer Aktiengesellschaft make?

Bayer Aktiengesellschaft (ETR:BAYN) has a market capitalization of $57.69 billion and generates $50.74 billion in revenue each year. The company earns $4.15 billion in net income (profit) each year or €4.19 on an earnings per share basis.

How many employees does Bayer Aktiengesellschaft have?

The company employs 95,950 workers across the globe.

How can I contact Bayer Aktiengesellschaft?

The official website for the company is www.bayer.com. The company can be reached via phone at 49 214 30 1.

This page (ETR:BAYN) was last updated on 4/2/2023 by MarketBeat.com Staff